Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivas Ramishetti

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Therapeutic Delivery|January 18, 2013
Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapySrinivas Ramishetti, Leaf Huang
Advanced Drug Delivery Reviews|December 12, 2018
Engineering lymphocytes with RNAiSrinivas Ramishetti, Dan Peer
Cancer Metastasis Reviews|May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapyDalit Landesman-Milo, Srinivas Ramishetti, Dan Peer
Journal of Drug Targeting|April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticlesSrinivas Ramishetti, Dalit Landesman-Milo, Dan Peer
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid NanoparticlesInbal Hazan-Halevy, Daniel Rosenblum, Srinivas Ramishetti, et al.
Molecular Pharmaceutics|December 7, 2011
Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma modelElizabeth A Vasievich, Srinivas Ramishetti, Yuan Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2013
Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphateJing Yao, Yuan Zhang, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 6, 2013
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasisZhenghong Xu, Srinivas Ramishetti, Yu-Cheng Tseng, et al.
Molecular Pharmaceutics|March 12, 2013
Multifunctional nanoparticles based on a single-molecule modification for the treatment of drug-resistant cancerDun Wang, Jingling Tang, Yongjun Wang, et al.
Theranostics|July 13, 2023
Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumorsYasmin Granot-Matok, Assaf Ezra, Srinivas Ramishetti, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Therapeutic Delivery|January 18, 2013
Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapySrinivas Ramishetti, Leaf Huang
Advanced Drug Delivery Reviews|December 12, 2018
Engineering lymphocytes with RNAiSrinivas Ramishetti, Dan Peer
Cancer Metastasis Reviews|May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapyDalit Landesman-Milo, Srinivas Ramishetti, Dan Peer
Journal of Drug Targeting|April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticlesSrinivas Ramishetti, Dalit Landesman-Milo, Dan Peer
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid NanoparticlesInbal Hazan-Halevy, Daniel Rosenblum, Srinivas Ramishetti, et al.
Molecular Pharmaceutics|December 7, 2011
Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma modelElizabeth A Vasievich, Srinivas Ramishetti, Yuan Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2013
Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphateJing Yao, Yuan Zhang, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 6, 2013
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasisZhenghong Xu, Srinivas Ramishetti, Yu-Cheng Tseng, et al.
Molecular Pharmaceutics|March 12, 2013
Multifunctional nanoparticles based on a single-molecule modification for the treatment of drug-resistant cancerDun Wang, Jingling Tang, Yongjun Wang, et al.
Theranostics|July 13, 2023
Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumorsYasmin Granot-Matok, Assaf Ezra, Srinivas Ramishetti, et al.
Pageof 4